Decatur Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Hold |
4,638
| – | – | 0.9% | 29 |
|
|
2025
Q1 | $2.25M | Buy |
4,638
+10
| +0.2% | +$4.85K | 1.17% | 25 |
|
|
2024
Q4 | $1.86M | Sell |
4,628
-67
| -1% | -$27K | 0.85% | 34 |
|
|
2024
Q3 | $2.18M | Sell |
4,695
-4,206
| -47% | -$1.96M | 1.01% | 32 |
|
|
2024
Q2 | $4.17M | Buy |
8,901
+221
| +3% | +$104K | 2.02% | 11 |
|
|
2024
Q1 | $3.63M | Sell |
8,680
-88
| -1% | -$36.8K | 1.97% | 13 |
|
|
2023
Q4 | $3.57M | Buy |
8,768
+2,780
| +46% | +$1.13M | 2.14% | 11 |
|
|
2023
Q3 | $2.08M | Hold |
5,988
| – | – | 1.5% | 17 |
|
|
2023
Q2 | $2.11M | Sell |
5,988
-70
| -1% | -$24.6K | 1.44% | 20 |
|
|
2023
Q1 | $1.91M | Sell |
6,058
-974
| -14% | -$307K | 1.44% | 22 |
|
|
2022
Q4 | $2.03M | Buy |
+7,032
| New | +$2.03M | 1.46% | 24 |
|
|
2021
Q2 | – | Sell |
-10,495
| Closed | -$2.26M | – | 68 |
|
|
2021
Q1 | $2.26M | Sell |
10,495
-9,473
| -47% | -$2.04M | 0.78% | 52 |
|
|
2020
Q4 | $4.72M | Sell |
19,968
-425
| -2% | -$100K | 0.86% | 51 |
|
|
2020
Q3 | $5.55M | Buy |
20,393
+3,865
| +23% | +$1.05M | 1.09% | 38 |
|
|
2020
Q2 | $4.8M | Buy |
+16,528
| New | +$4.8M | 1.27% | 30 |
|